✦ LIBER ✦

Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma

✍ Scribed by Edwin R. Fisher; Stewart Anderson; Scott Dean; David Dabbs; Bernard Fisher; Richard Siderits; Jeffrey Pritchard; Telma Pereira; Charles Geyer; Norman Wolmark

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 134 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20761

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of premenopausal breast carcino

Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor

✍ Lucienne S. Cooper; Cheryl E. Gillett; Neera K. Patel; Diana M. Barnes; Ian S. F 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 3 views

## BACKGROUND. Premenopausal breast carcinoma patients who undergo tumor excision during the follicular phase of their menstrual cycle may have a significantly worse prognosis than those whose tumors are excised in other phases of the menstrual cycle. ## METHODS. Outcome was determined in a ser

The role of human epidermal growth facto

The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: The California Cancer Registry, 1999–2004

✍ Monica Brown; Alex Tsodikov; Katrina R. Bauer; Carol A. Parise; Vincent Caggiano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

## Abstract ## BACKGROUND Breast cancers that are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (triple negative [TN]) have been associated with high‐grade histology, aggressive clinical behavior, and poor survival. It has been